Historique
Rapport
Evidence for the effectiveness of interventions to prevent infections among people who inject drugs. Part 1 : Needle and syringe programmes and other interventions for preventing hepatitis C, HIV and injecting risk behaviour
Accompagne :
Auteur(s) :
European Centre for Disease Prevention and Control (ECDC) ;
OEDT = EMCDDA (Observatoire européen des drogues et des dépendances = European monitoring centre for drugs and drug addiction)
Année
2011
Page(s) :
103 p.
Sous-type de document :
Revue de la littérature / Literature review
Langue(s) :
Anglais
Éditeur(s) :
Stockholm : ECDC (European Centre for Disease Prevention and Control)
;
Lisbon : OEDT / EMCDDA
Collection :
Technical report
ISBN :
978-92-9193-316-7
Domaine :
Drogues illicites / Illicit drugs
Discipline :
MAL (Maladies infectieuses / Infectious diseases)
Thésaurus mots-clés
REDUCTION DES RISQUES ET DES DOMMAGES
;
EFFICACITE
;
INTERVENTION
;
PREVENTION
;
INFECTION
;
USAGER
;
HEPATITE
;
VIH
;
CONDUITE A RISQUE
;
ECHANGE DE SERINGUES
;
EVALUATION
Résumé :
This is the first of two technical reports that present the evidence behind the "Guidance on the prevention and control of infectious diseases among people who inject drugs".
The evidence presented here focuses on the effectiveness (and in some cases the cost-effectiveness) of the following interventions: the provision of needles and syringes; the provision of other (non-needle and syringe) drug preparation equipment; the provision of foil to stimulate route transition; the provision of information, education and counselling; knowledge of hepatitis C status; disease treatment; modes of service delivery including supervised injecting facilities; and access to, retention in, and combination of interventions.
The evidence presented here focuses on the effectiveness (and in some cases the cost-effectiveness) of the following interventions: the provision of needles and syringes; the provision of other (non-needle and syringe) drug preparation equipment; the provision of foil to stimulate route transition; the provision of information, education and counselling; knowledge of hepatitis C status; disease treatment; modes of service delivery including supervised injecting facilities; and access to, retention in, and combination of interventions.